Concepedia

Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer

John P. Micha, Bram H. Goldstein, Julie A. Mattison, K Bader, Cheri L Graham, Mark A. Rettenmaier, John V. Brown, Maurie Markman

Gynecologic Oncology · 2004 · 23 citations · 15 references

DOI

Concepts

References

15

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

, , +17

Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

Maurie Markman, Pan Liu, Sharon P. Wilczynski et al. · Journal of Clinical Oncology · 2003 · 458 citations

, , +13

Phase II Trial of Weekly Single-Agent Paclitaxel in Platinum/Paclitaxel-Refractory Ovarian Cancer

Maurie Markman, James B. Hall, Daniel L. Spitz et al. · Journal of Clinical Oncology · 2002 · 211 citations

, , +17

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Gordon Rustin, Maria Marples, Ann E. Nelstrop et al. · Journal of Clinical Oncology · 2001 · 203 citations

, , +17

A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)

K. Bertelsen, Anders Jakobsen, I. Strøyer et al. · Gynecologic Oncology · 1993 · 154 citations

, , +9